Friday, February 20, 2015

United Therapeutics - Barchart's Chart of the Day

United Therapeutics (UTHR) is the Barchart Chart of the Day.  The biomedical stock has a Trend Spotter buy signal and Weighted Alpha of 58.00+ and gained 51.91% in the last year.

The Chart of the Day is United Therapeutics (UTHR).  I found the stock by sorting the All Time High list for the stocks with the highest Technical buy signals then used the Flipchart feature to review the charts,  Since the Trend Spotter signaled a buy on 1/13 the stock gained 15.60%.

United Therapeutics is a biotechnology company focused on combating cardiovascular, inflammatory, and infectious diseases with unique therapeutic products. These products include pharmaceuticals, arginine products and telemedicine services.


Barchart's Opinion trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com web site when you read this report.


Barchart technical indicators:

  • 100% Barchart technical buy signals
  • Trend Spotter buy signal
  • Above its 20, 50 and 100 day moving averages
  • 7 new highs and up 10.10% in the last month
  • Relative Strength Index 76.59%
  • Barchart computes a technical support level at 152.48
  • Recently traded at 155.72 with a 50 day moving average of 137.69
Fundamental factors:
  • Market Cap $7.40 billion
  • P/E 42.98
  • Revenue expected to grow 1450% this year and another 15.20% next year
  • Earnings estimated to increase by 96.60% this year, an additional 53.20% next year and continue to compound at an annual rate of 27.63% for the next 5 years
  • Wall Street analysts issued 2 strong buy, 4 buy, 9 hold and 2 under perform recommendations on the stock
The 100 day moving average vs the price has been an effective technical trading strategy on this stock and should continue to be used for entry and exit points.

No comments:

Post a Comment